NV-5440

NV-5440 is a drug which acts as both a non-specific inhibitor of the glucose transporters and also a selective inhibitor of mTORC1, with no significant action at the related mTORC2 subtype. Compounds of this type have potential application in the treatment of cancer, and it is also used for research into the links between calorie restriction and longevity.[1][2][3]

NV-5440
Identifiers
  • 2-[4-[5-[[4-(2-cyanophenyl)piperazin-1-yl]methyl]-2,4-dimethylbenzoyl]piperazin-1-yl]benzenesulfonamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC31H36N6O3S
Molar mass572.73 g·mol−1
3D model (JSmol)
  • CC1=CC(=C(C=C1CN2CCN(CC2)C3=CC=CC=C3C#N)C(=O)N4CCN(CC4)C5=CC=CC=C5S(=O)(=O)N)C
  • InChI=1S/C31H36N6O3S/c1-23-19-24(2)27(20-26(23)22-34-11-13-35(14-12-34)28-8-4-3-7-25(28)21-32)31(38)37-17-15-36(16-18-37)29-9-5-6-10-30(29)41(33,39)40/h3-10,19-20H,11-18,22H2,1-2H3,(H2,33,39,40)
  • Key:BREWSTIKWAQLCH-UHFFFAOYSA-N

References
  1. Kang SA, O'Neill DJ, Machl AW, Lumpkin CJ, Galda SN, Sengupta S, et al. (September 2019). "Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters". Cell Chemical Biology. 26 (9): 1203–1213.e13. doi:10.1016/j.chembiol.2019.05.009. PMID 31231029.
  2. Reckzeh ES, Waldmann H (May 2020). "Development of Glucose Transporter (GLUT) Inhibitors". European Journal of Organic Chemistry. 2020 (16): 2321–2329. doi:10.1002/ejoc.201901353. PMC 7217229. PMID 32421048.
  3. Reckzeh ES, Waldmann H (January 2020). "Small-Molecule Inhibition of Glucose Transporters GLUT-1-4". ChemBioChem. 21 (1–2): 45–52. doi:10.1002/cbic.201900544. PMC 7004114. PMID 31553512.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.